mynth
← DATABASE
09/2020

PSB INDUSTRIES (HEALTHCARE & INDUSTRY) acquired by CLAYENS GROUP

FRANCE Chemicals & Materials / Material Transformation / Plastics REV 50M - 100M EUR

Context

This operation represents the first programmatic bolt-on acquisition executed by Clayens NP since its primary sponsor-backed buyout, designed to accelerate the platform’s diversification into highly resilient and high-margin healthcare manufacturing verticals. Negotiated on a proprietary bilateral basis due to long-standing industrial relationships and a previous site acquisition in 2017, the transaction allows the seller, PSB Industries, to complete its strategic pivot toward luxury and beauty packaging while divesting a non-core industrial asset. The acquisition adds >€50 million in revenue to Clayens NP, driving consolidated group sales toward €350 million and establishing an essential manufacturing bridgehead in Mexico to serve the North American nearshoring market. The transaction funding mechanism leverages a combination of available balance sheet cash and a structured share swap, resulting in PSB Industries taking a minor equity position within the Clayens holding structure alongside the existing sponsor pool and management. This structural alignment facilitates management continuity, ensures operational stability across the five acquired sites, and underpins the strategic cross-selling of polymer and cleanroom manufacturing capabilities to the combined global customer base.

PSB INDUSTRIES (HEALTHCARE & INDUSTRY), which reported an EBITDA margin of in 2020, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Industry & Manufacturing sector (11.6x).

-> Deep-dive in Industry & Manufacturing market trends

Target

The healthcare and industry division of PSB Industries operates as a highly specialized technical contract manufacturer of advanced polymer components and precision plastic assemblies across five manufacturing facilities located in France, Poland, and Mexico. The operational infrastructure is defined by the utilization of five certified ISO7 cleanroom environments, which are technically mandatory to comply with the rigid sanitary, regulatory, and validation standards governing the medical, pharmaceutical, and diagnostic end-markets. Revenue generation within this business unit is derived from long-term supply arrangements linked to customer-owned proprietary tooling and injection molds, creating deep commercial integration and high customer switching costs that protect the asset from volume volatility.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2020
2019

Similar deals in Chemicals & Materials

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
DateAcquirerTargetCountrySector
11/2020CRODA INTERNATIONALIBERCHEM GROUPSPAINFlavors & Fragrances
10/2020ARDIANADVANCION (ANGUS CHEMICAL)UNITED STATESSpecialty Chemicals
07/2020PARTNERS GROUPRovensaPORTUGALSpecialty Chemicals
06/2020CEREA PARTNERS / BPIFRANCEAXIUM PACKAGINGFRANCEPlastic Packaging
03/2020ALLIANCE ETIQUETTES5 SEPT ETIQUETTEFRANCELabels & Adhesives
03/2020SPARRING CAPITALPURE TRADE WORLDWIDEFRANCEPackaging & Containers
02/2020SOFIMAC REGIONS / ESFIN PARTICIPATIONSPONCIN METALFRANCEMetallurgy / Foundry
01/2020COBEPAGERFLORFRANCEFlooring
01/2020KAMAN CORPORATIONBAL SEAL ENGINEERINGUNITED STATESPlastics
12/2019GREEN ARROW CAPITALPOPLASTITALYPlastic Packaging

REFERENCES

Revenue range: 50M - 100M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of PSB INDUSTRIES (HEALTHCARE & INDUSTRY) by CLAYENS GROUP are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Acquirer: clayens group